Bids Are invited for Ifa 11 Re Drugs
Tender Overview
Project Description
Bids Are invited for Ifa 11 Re Drugs Insulin Highly Purified Isophane Human Nph 40Iu , Tirzepatide 5 Mg Inj , Tirzepatide 2 Point5 Mg Inj , Liothyronine 20 Mcg Tab , Imeglimin 1000 Mg Tab , Tirzepatide 12 Point 5 Mg Per 0 Per 6 Ml In Multidose Pre , Tirzepatide 10 Mg Per 0 Point 6 Ml In Multidose Prefilled , Inj Somatrogon 60 Mg Prefilled Pen , Romosozumab Inj 105 Mg Per 1Point 17 Ml , Corticotropin Carboxymethylcellulose 60 Iu Per Ml Coma 300 Mg , Semaglutide 0 Point 25 Mg Inj , Semaglutide 0 Point 50 Mg Inj , Semaglutide 1Point 0 Mg Inj 1Point 5 Ml Pfs , Semaglutide 1 Point 7 Mg Inj , Semaglutide 2Point 4 Mg Inj , Tirzepatide 7 Ponit 5 Mg Inj Multidose Pfp , Desmopressin Acetate Tablet 60Mcg Sublingual , Desmopressin Acetate 0 Point 1 Mg Tab , Desmopressin Nasal Spray 0 Point 1Mg Per Ml In Vial Of , Diazoxide 25 Mg Tab , Fludrocortisone 0 Point 1Mg Tab , Carbimazole 20 Mg Tab , Hydrocortisone 5 Mg Tab , Propylthiouracil 50Mg Tab , Carbimazole 5Mg Tab , Hydrocortisone 20Mg Tab , Disposable Needle Compatible With All Insulin Pen , Tirzepatide 15 Mg Inj Multidose Pfp
Corrigendum
| Sr No | Corrigendum Date | Corrigendum | Type | New Submission Date |
|---|---|---|---|---|
| 1 | 21-Aug-2026 | 28-Aug-2026 |
BOQ
| Sl. No. | Item Title | Item Description |
| 1 | Insulin highly purified Isophane Human NPH 40IU | Insulin highly purified Isophane Human NPH 40IU |
| 2 | Tirzepatide 5 mg Inj | Tirzepatide 5 mg Inj |
| 3 | Tirzepatide 2 point5 mg Inj | Tirzepatide 2 point5 mg Inj |
| 4 | Liothyronine 20 mcg Tab | Liothyronine 20 mcg Tab |
| 5 | Imeglimin 1000 mg Tab | Imeglimin 1000 mg Tab |
| 6 | Tirzepatide 12 point 5 mg per 0 per 6 ml in multidose pre | Tirzepatide 12 point 5 mg per 0 per 6 ml in multidose pre |
| 7 | Tirzepatide 10 mg per 0 point 6 ml in multidose prefilled | Tirzepatide 10 mg per 0 point 6 ml in multidose prefilled |
| 8 | Inj Somatrogon 60 mg Prefilled Pen | Inj Somatrogon 60 mg Prefilled Pen |
| 9 | Romosozumab Inj 105 mg per 1point 17 ml | Romosozumab Inj 105 mg per 1point 17 ml |
| 10 | Corticotropin Carboxymethylcellulose 60 IU per ml coma 300 mg | Corticotropin Carboxymethylcellulose 60 IU per ml coma 300 mg |
| 11 | Semaglutide 0 point 25 mg Inj | Semaglutide 0 point 25 mg Inj |
| 12 | Semaglutide 0 point 50 mg Inj | Semaglutide 0 point 50 mg Inj |
| 13 | Semaglutide 1point 0 mg Inj 1point 5 ml PFS | Semaglutide 1point 0 mg Inj 1point 5 ml PFS |
| 14 | Semaglutide 1 point 7 mg Inj | Semaglutide 1 point 7 mg Inj |
| 15 | Semaglutide 2point 4 mg Inj | Semaglutide 2point 4 mg Inj |
| 16 | Tirzepatide 7 ponit 5 mg Inj Multidose PFP | Tirzepatide 7 ponit 5 mg Inj Multidose PFP |
| 17 | Desmopressin Acetate Tablet 60mcg Sublingual | Desmopressin Acetate Tablet 60mcg Sublingual |
| 18 | Desmopressin acetate 0 point 1 mg Tab | Desmopressin acetate 0 point 1 mg Tab |
| 19 | Desmopressin Nasal spray 0 point 1mg per ml in vial of | Desmopressin Nasal spray 0 point 1mg per ml in vial of |
| 20 | Diazoxide 25 mg Tab | Diazoxide 25 mg Tab |
| 21 | Fludrocortisone 0 point 1mg Tab | Fludrocortisone 0 point 1mg Tab |
| 22 | Carbimazole 20 mg Tab | Carbimazole 20 mg Tab |
| 23 | Hydrocortisone 5 mg Tab | Hydrocortisone 5 mg Tab |
| 24 | Propylthiouracil 50mg Tab | Propylthiouracil 50mg Tab |
| 25 | Carbimazole 5mg Tab | Carbimazole 5mg Tab |
| 26 | Hydrocortisone 20mg Tab | Hydrocortisone 20mg Tab |
| 27 | Disposable needle compatible with all insulin Pen | Disposable needle compatible with all insulin Pen |
| 28 | Tirzepatide 15 mg Inj Multidose PFP | Tirzepatide 15 mg Inj Multidose PFP |
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedCorrigendum-1 Issued
Clarifications on tender conditions and amendments issued.
Upcoming · 5 daysBid Submission Deadline
Online submission via eProcurement portal.
Upcoming · 5 daysBid Opening Date
Technical bids will be opened and evaluated.
Upcoming · 5 daysTender Documents
Download All (ZIP) ↓We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender